Sanofi’s $17bn sale of Opella to US investors advances following government deal
A stake by France-owned Bpifrance and promise of local job retention have allayed political backlash over the sale of Sanofi’s consumer health business.
A stake by France-owned Bpifrance and promise of local job retention have allayed political backlash over the sale of Sanofi’s consumer health business.
An 800% increase in licensing deal values indicates growing confidence in mRNA technology.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
GITEX GLOBAL 2024: Huawei launches a series of industrial digital and intelligent transformation solutions, and flagship products
XtalPi’s AI biologics discovery platform licensed to Janssen Biotech
Lilly and insitro team up to develop AI-powered siRNA metabolic drugs
Advancing Pharmaceutical Security: The Role of SECURtracers in On-Dose Authentication